from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0737/-

LFCtreatmentdescriptionclass of inhibitor

-0.354

Amikacinug/mL Amikacintranslation

0.253

Cap5-10ug/mL Capreomycintranslation

0.535

Rox10-50 ug/mL Roxithromycintranslation

-0.943

SM2-5 ug/mL Streptomycintranslation

-1.098

Tet5-10 ug/mL Tetracyclinetranslation

0.657

Rif0.2-5ug/mL Rifampicintranscription

-0.079

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.004

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.823

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.470

CPZ10-50 ug/mL Chlorpromazinerespiration

0.076

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.137

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.565

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.004

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.268

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.297

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.458

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.645

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.006

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.424

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.761

KCN5-20 ug/mL Potassium cyaniderespiration

-1.573

NaN30.2-2 mM Sodium aziderespiration

-0.557

Nigericin50 uM Nigericinrespiration

0.322

TRC10-150 ug/mL Triclosanrespiration

-0.829

TRZ10-25 ug/mL Thioridazinerespiration

0.654

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.607

menadione6-10 ug/mL Menadionerespiration

1.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.147

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.382

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.024

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.553

NRP_1Non-replicating persistence stage 1dosRassociated

0.203

Amp0.2mg/mL AmpicillincellWall

-0.066

Cephalexin20-100 ug/mL CephalexincellWall

-0.930

Cerulenin0.32-5 ug/mL CerulenincellWall

0.150

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.394

EMB10-20 ug/mL EthambutolcellWall

0.591

Eta12-40 ug/mL EthionamidecellWall

-0.087

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.271

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.414

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.104

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.231

BZA0.12 mg/mL BenzamidearomaticAmides

0.168

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.049

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.659

H2O24 mM hydrogen peroxideDNAdamaging

-0.018

Levo10 ug/mL LevofloxacinDNAdamaging

-0.041

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.306

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.141

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.066

UVUV-irradiationDNAdamaging

2.336

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.521

Antimycin12.5-50 ug/mL Antimycin A?

0.220

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.597

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.597

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.028

PA8240.2-2 ug/mL PA-824?

-0.173

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.078

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.253

Verapamil50 uM Verapamil?

-0.527

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.125

methoxatin10-20 ug/mL Methoxatin?